Czech Health Spending To Rise 10.1% In 1995

9 October 1994

The Czech Republic's draft budget for health care in 1995 is a provisional 7.6 billion koruna ($271.5 million), up 10.1% on 1994, reports the CTK news agency's Business News. 4 billion koruna will go to the state and 3.6 billion koruna to districts and municipalities for the provision of health care services.

CTK Business News also reports that Slovak output of chemicals and medicines rose 4% in the first seven months of 1994 over the like, year-earlier period.

Moreover, it notes, the government plans to introduce legislation to curb exaggerated advertising claims for medicines. And Health Minister Ludek Rubas has criticized doctors for prescribing high-priced medicines, noting that health care costs have almost doubled in the past four years. However, he noted that patient satisfaction with health care has risen and health indices are improving, although reform has been hampered by fears that a transition period could mean a fall in health care standards.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight